These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33753396)

  • 1. Double-edged sword effect of anticoagulant in COVID-19 infection.
    Ohn MH; Ng JR; Ohn KM; Luen NP
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33753396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study.
    Di Micco P; Tufano A; Cardillo G; Imbalzano E; Amitrano M; Lodigiani C; Bellizzi A; Camporese G; Cavalli A; De Stefano C; Russo V; Voza A; Perrella A; Prandoni P
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis.
    Dybowska M; Wyrostkiewicz D; Opoka L; Lewandowska K; Sobiecka M; Tomkowski W; Szturmowicz M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline.
    Lederle FA; Zylla D; MacDonald R; Wilt TJ
    Ann Intern Med; 2011 Nov; 155(9):602-15. PubMed ID: 22041949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19.
    Dobesh PP; Trujillo TC
    Pharmacotherapy; 2020 Nov; 40(11):1130-1151. PubMed ID: 33006163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients.
    Vergori A; Pianura E; Lorenzini P; D'Abramo A; Di Stefano F; Grisetti S; Vita S; Pinnetti C; Donno DR; Marini MC; Nicastri E; Ianniello S; Antinori A;
    Ann Med; 2021 Dec; 53(1):295-301. PubMed ID: 33491498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal muscle haemorrhage attributable to heparin administration in a patient with dermatomyositis.
    Higashi Y; Mera K; Kanzaki T; Kanekura T
    Clin Exp Dermatol; 2009 Apr; 34(3):448-9. PubMed ID: 19309387
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year.
    Leentjens J; van Haaps TF; Wessels PF; Schutgens REG; Middeldorp S
    Lancet Haematol; 2021 Jul; 8(7):e524-e533. PubMed ID: 33930350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe practice for patients receiving anticoagulant therapy.
    Lankshear A; Harden J; Simms J
    Nurs Stand; 2010 Jan 20-26; 24(20):47-54; quiz 56. PubMed ID: 20191745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials.
    Pilia E; Belletti A; Fresilli S; Finco G; Landoni G
    J Thromb Thrombolysis; 2022 Oct; 54(3):420-430. PubMed ID: 35922578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Ghana-UK haematology "heparin" partnership.
    Olayemi E; Davies R; Bates I
    Br J Haematol; 2020 Nov; 191(3):e96-e97. PubMed ID: 32798238
    [No Abstract]   [Full Text] [Related]  

  • 15. Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action.
    Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
    Thromb Res; 2020 Dec; 196():313-317. PubMed ID: 32977129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorrhagic complications of anticoagulant treatment.
    Levine MN; Raskob G; Landefeld S; Kearon C
    Chest; 2001 Jan; 119(1 Suppl):108S-121S. PubMed ID: 11157645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status.
    Li W; Xu Z; Xiang H; Zhang C; Guo Y; Xiong J
    Aging (Albany NY); 2021 Mar; 13(7):9225-9242. PubMed ID: 33818421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety profile of enhanced thromboprophylaxis strategies for critically ill COVID-19 patients during the first wave of the pandemic: observational report from 28 European intensive care units.
    Lavinio A; Ercole A; Battaglini D; Magnoni S; Badenes R; Taccone FS; Helbok R; Thomas W; Pelosi P; Robba C;
    Crit Care; 2021 Apr; 25(1):155. PubMed ID: 33888132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients.
    Dentali F; Douketis JD; Gianni M; Lim W; Crowther MA
    Ann Intern Med; 2007 Feb; 146(4):278-88. PubMed ID: 17310052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major hemorrhage and mortality in COVID-19 patients on therapeutic anticoagulation for venous thromboembolism.
    Prince MR; Dev H; Lane EG; Margolis DJ; DeSancho MT
    J Thromb Thrombolysis; 2022 Oct; 54(3):431-437. PubMed ID: 35689139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.